The effect of guselkumab on inhibiting radiographic progression in patients with active psoriatic arthritis: study protocol for APEX, a Phase 3b, multicenter, randomized, double-blind, placebo-controlled trial.
Christopher T RitchlinLaura C CoatesPhilip J MeaseDésirée van der HeijdeJiao SongYusang JiangMay ShawiAlexa P KollmeierProton RahmanPublished in: Trials (2023)
This trial was registered at ClinicalTrials.gov, NCT04882098 . Registered on 11 May 2021.